Negative control for EED inhibitor EED226

Negative control compound for UNC3866 which is a potent antagonist of the methyllysine (Kme) reading function of the Polycomb CBX and CDY families of chromodomains

FIT-039 is a potent, selective CDK9 inhibitor with IC50 of 5.8 uM for CKD9/cyclin T1, suppresses the replication of HSV-1 (IC50=0.69 uM).

Negative control for UCSF924

Cell impermeant homolog of UCD38B, inhibitor of uPA (urokinase plasminogen activator)

Negative control for TP-004

Negative control for TP-238

Negative control for TP-040

Negative control for THPP-1

Novel potent and selective NUDT15 inhibitor (MG IC50 = 35 nM), potentiating the anti-HCMV efficacy of ganciclovir

Negative control for TH1760

Metabolite of Telmisartan

Novel novel anti-tuberculosis (TB) agent, possessing improved safety properties compared to bedaquiline

Cell permeable Cx43 hemichannel blocker, being used a control peptide for TAT-Gap19

Negative control for T3-CLK

Prodrug of ADAM17 inhibitor SN-4

Negative control for SGC-STK17B-1, showing IC50 > 10,000 nM against STK17B

Negative control for SGC-CLK-1

Negative control for SGC-CK2-1

Negative control for SGC-CAMKK2-1

Negative control for SGC-SMARCA-BRDVIII

Novel cell permeable CD45 phosphatase inhibitor; Prodrug of RWJ-60475

Metabolite of ozanimod, exhibiting a similar specificity profile as ozanimod at the S1P receptor family in vitro and pharmacodynamic profile in vivo

Negative control for Borussertib, being >1000 fold less potent in vitro than Borussertib

Clickable Remodelin analog

Prodrug of RO5203548, a selective agonist of the trace amine-associated receptor 1 (TAAR1)

Novel Orally Bioavailable Prodrug of Boronic Acid β-Lactamase Inhibitor QPX7728

An isomer of PU-H54, a novel Grp94- and Hsp90-selective inhibitor

Prodrug of DMOCPTL

Negative control for Primordazine A and Primordazine B